Repligen
RGEN
#1859
Rank
HK$86.96 B
Marketcap
HK$1,360
Share price
2.97%
Change (1 day)
20.10%
Change (1 year)
Categories

EPS for Repligen (RGEN)

EPS in 2023 (TTM): HK$16.36

According to Repligen 's latest financial reports the company's current EPS (TTM) is -HK$1.57. In 2022 the company made an earnings per share (EPS) of HK$26.35 an increase over its 2021 EPS that were of HK$18.35.

EPS history for Repligen from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$16.36-37.89%
2022HK$26.3543.59%
2021HK$18.35105.26%
2020HK$8.94153.33%
2019HK$3.5318.42%
2018HK$2.98-47.95%
2017HK$5.72108.57%
2016HK$2.7420.69%
2015HK$2.2716%
2014HK$1.96-48.98%
2013HK$3.846.52%
2012HK$3.61-512.88%
2011-HK$0.87-1214.13%
2010HK$0.07841-106.25%
2009-HK$1.25-200%
2008HK$1.25-87.79%
2007HK$10.27-2283.33%
2006-HK$0.47-300%
2005HK$0.24-115%
2004-HK$1.57-25.93%
2003-HK$2.1280%
2002-HK$1.18-21.05%
2001-HK$1.49-0%
2000-HK$1.49-17.39%
1999-HK$1.80245.01%
1998-HK$0.5233.33%
1997-HK$0.39-87.18%
1996-HK$3.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$5.96-480.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
HK$148.91-9,595.00%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
HK$68.46-4,465.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.44-2,360.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-HK$2.98 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-HK$11.92 660.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
HK$55.28-3,625.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
HK$9.17-685.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$2.98-290.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-HK$37.95 2,320.00%๐Ÿ‡บ๐Ÿ‡ธ USA